1Devy L, Blacher S, Grignet-Debrus C, et al. The pro- or antiangigenic effect of plasminogen activator inhibitor 1 is dose-dependent[J]. SEB J, 2000,16: 147-154.
2Chapman HA, Wei Y. Protease crosstalk with intergrins:the urokinase receptor paradigm[J]. Thromb Haemost,2001, 86:124-129.
3Lijnen HR. Pathophysiology of the plasminogen/ plasmin system[J]. Int J Clin Lab Res, 1996, 26 (1):1-6.
4Burnand KG, Gaffney PS, Mc Guinnessll, et al. The role of the monocyte in the generation and dissolution of arterial and venous thrombosis[J]. Cardiovasc Surg, 1998,6: 119-125.
5Falkon L, Gari M, Borrell M, et al. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis[J]. Blood Coagul Fibrinolysis, 1992, 3 (1): 33-38.
6Kelly J, Rudd A, Lewis RR, et al. Plasma D-dimers in the diagnosis of venous thromboembolism[J]. Arch Intern Med, 2002,162: 747-756.
3Nijkeuter M, Ginsberg JS, Huisman MV. Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review [ J ]. J Thromb Haemost, 2006,4 ( 3 ) : 496 - 500.
4De Moerloose P, Bounameaux H, Wells PH. D - dimer testing and venous thromboembolism : four view points [ J ]. J ThrombHaemost,2005,3 (2) :380 - 382.
5Haenssle HA, Ayad N, Buhl T, et al. Limited diagnostic value of Wells - score and D - dimer testing in hospitalized derma- tologic patients with symptoms of deep vein thrombosis [ J ]. Eur J Dermatol,2013,23 (6) :830 - 836.
6Geersing GJ,Zuithoff NP, Kearon C, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups : individual patient data meta - analysis [ J ]. BMJ,2014, (348) : 1340.
7E1 Tabei L, Hohz G, Schtirer - Maly C, et al. Accuracy in di- agnosing deep and pelvic vein thrombosis in primary care:an analysis of 395 cases seen by 58 primary care physicians [ J . Dtsch Arztebl Int,2012,109 (45) : 761 - 766.
